NEW YORK (GenomeWeb) – Quanterix said today that it has closed its initial public offering, selling more than 4.9 million shares of common stock at $15 per share, raising $73.7 million in gross proceeds. Its shares now trade on the Nasdaq under ticker symbol QTRX.
In early afternoon trading, the company's stock was up about 5 percent at $19.08 per share.
JP Morgan Securities, Leerink Partners, and Cowen were joint book-running managers for the offering, while BTIG and Evercore Group were comanagers.
The firm previously said it would use the proceeds from its IPO to expand its commercial operations and grow its existing technology. Its plans include launching additional assays for its single-molecule technology Simoa and supporting the launch of its new instrument, Quanterix SR-X, which it launched in August.